Document Detail

Diagnostic use of anti-modified nucleoside monoclonal antibody.
MedLine Citation:
PMID:  1306318     Owner:  NLM     Status:  MEDLINE    
By use of monoclonal antibodies (MoAbs) termed APU-6 and AMA-2, we determined the usefulness of urinary modified nucleosides, pseudouridine and 1-methyladenosine, as markers for malignancy. In patients with leukemia and other forms of cancer, these nucleosides elevated significantly and reflected the disease status of patients. The immunohistochemical analysis showed that cancer cells were specifically stained with the MoAbs. Chemical identification of the cellular components reactive with the MoAbs revealed that APU-6-associated antigens were mainly rRNA and AMA-2-associated antigens were mainly tRNA. These results suggest that APU-6 and AMA-2 would be useful tools for clinical and biological studies of cancer.
K Itoh; S Ishiwata; N Ishida; M Mizugaki
Related Documents :
10668568 - Bladder exstrophy: staged reconstruction.
3318088 - Bcg in management of superficial bladder cancer.
21572298 - Primary care perspectives on prostate cancer screening.
9866458 - Metastatic spread and common symptoms. part one: introduction, bladder cancer, and brai...
17975498 - The impact of genetic markers on the diagnosis of lung cancer: a current perspective.
19709168 - Short- and long-term survival of patients with metastatic solid cancer admitted to the ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Tohoku journal of experimental medicine     Volume:  168     ISSN:  0040-8727     ISO Abbreviation:  Tohoku J. Exp. Med.     Publication Date:  1992 Oct 
Date Detail:
Created Date:  1993-08-05     Completed Date:  1993-08-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0417355     Medline TA:  Tohoku J Exp Med     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  329-31     Citation Subset:  IM    
Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenosine / analogs & derivatives*,  urine
Antibodies, Monoclonal / diagnostic use*
Antibody Specificity
Immunoenzyme Techniques
Leukemia / urine*
Lymphoma / urine*
Monitoring, Physiologic / methods
Pseudouridine / urine*
Tumor Markers, Biological / urine*
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Tumor Markers, Biological; 1445-07-4/Pseudouridine; 15763-06-1/1-methyladenosine; 58-61-7/Adenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  New strategies to establish human monoclonal antibodies.
Next Document:  Selective anti-gene therapy for cancer: principles and prospects.